The Alzheimer's Disease Gene SORL1 Regulates Lysosome Function in Human Microglia
Glia · 2025-07 · 73 (7) · 1329-1348
DOI: 10.1002/glia.70009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, online erschienen am 04.04.2025. Verfasst von Swati Mishra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Lysosomes, Microglia, LDL-Receptor Related Proteins, Alzheimer Disease. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIDDK NIH HHS, Alzheimer's Association.
Themen: Demenz
Abstract (Originalsprache)
The SORL1 gene encodes the sortilin‐related receptor protein SORLA, a sorting receptor that regulates endo‐lysosomal trafficking of various substrates. Loss of function variants in SORL1 are causative for Alzheimer's disease ( AD ) and decreased expression of SORLA has been repeatedly observed in human AD brains. SORL1 is highly expressed in the central nervous system, including in microglia, the tissue‐resident immune cells of the brain. Loss of SORLA leads to enlarged lysosomes in hiPSC‐derived microglia‐like cells (hMGLs). However, how SORLA deficiency contributes to lysosomal dysfunction in microglia and how this contributes to AD pathogenesis is not known. In this study, we show that loss of SORLA results in decreased lysosomal degradation and lysosomal enzyme activity due to altered trafficking of lysosomal enzymes in hMGLs. Phagocytic uptake of fibrillar amyloid beta 1–42 and synaptosomes is increased in SORLA‐deficient hMGLs, but due to reduced lysosomal degradation, these substrates aberrantly accumulate in lysosomes. An alternative mechanism of lysosome clearance, lysosomal exocytosis, is also impaired in SORL1 ‐deficient microglia, which may contribute to an altered immune response. Overall, these data suggest that SORLA has an important role in the proper trafficking of lysosomal hydrolases in hMGLs, which is critical for microglial function. This further substantiates the microglial endo‐lysosomal network as a potential novel pathway through which SORL1 may increase AD risk and contribute to the development of AD . Additionally, our findings may inform the development of novel lysosome and microglia‐associated drug targets for AD .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
- Institute of Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington, USA.
- Boston Children's Hospital, F.M. Kirby Neurobiology Center, Boston, Massachusetts, USA.
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
- Howard Hughes Medical Institute, Boston, Massachusetts, USA.
- Department of Neurology, University of Washington, Seattle, Washington, USA.
ORCID-Profile: Suman Jayadev, Jessica E Young
Förderung
- NIA NIH HHS
- NIDDK NIH HHS
- Alzheimer's Association
- National Institute on Aging
Zitieren
APA
Mishra, S., Morshed, N., Sidhu, S. B., Kinoshita, C., Stevens, B., Jayadev, S., & Young, J. E. (2025). The Alzheimer's Disease Gene SORL1 Regulates Lysosome Function in Human Microglia. Glia, 73(7), 1329-1348. https://doi.org/10.1002/glia.70009
Vancouver
Mishra S, Morshed N, Sidhu SB, Kinoshita C, Stevens B, Jayadev S, et al. The Alzheimer's Disease Gene SORL1 Regulates Lysosome Function in Human Microglia. Glia. 2025;73(7):1329-1348. doi:10.1002/glia.70009
BibTeX
@article{Mishra2025,
author = {Mishra, Swati and Morshed, Nader and Sidhu, Sonia Beant and Kinoshita, Chizuru and Stevens, Beth and Jayadev, Suman and Young, Jessica E},
title = {The Alzheimer's Disease Gene SORL1 Regulates Lysosome Function in Human Microglia},
journal = {Glia},
year = {2025},
volume = {73},
number = {7},
pages = {1329--1348},
doi = {10.1002/glia.70009}
}
EUVIMED